Concepedia

Catherine Tribouley

CT

10

Publications

1.2K

Citations

10

H-Index

1992

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Novartis (United States)

Novartis (Switzerland)

University Medical Center Groningen

Centre National de la Recherche Scientifique

Catherine Tribouley is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and gene expression.

Top concepts

MedicineImmunologyAsthmaAllergyGeneticsCell BiologyInflammationImmunotherapyGene ExpressionSystems Biology

Publications per year

1992–2018

10

Publications

10

Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

Elena J. Orlando, Xia Han, Catherine Tribouley et al. · Nature Medicine · 2018 · 542 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +11

Molecular Signature of Smoking in Human Lung Tissues

Yohan Bossé, Dirkje S. Postma, Don D. Sin et al. · Cancer Research · 2012 · 136 citations

Asthma, Tobacco Control, Gene Expression Signature +15

The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter

Catherine Tribouley, Pierre G. Lutz, Adrien Staub et al. · Journal of Virology · 1994 · 110 citations · Full text

Viral Replication, Major Late Promoter, Lytic Infection +17

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Jianxiang Wang, Zhixiang Shen, Giuseppe Saglio et al. · Blood · 2015 · 108 citations · Full text

Characterization of a New Member of the TNF Family Expressed on Antigen Presenting Cells

Catherine Tribouley, Marco Wallroth, Vivien W. Chan et al. · Biological Chemistry · 1999 · 99 citations

Rows per page

1–5 of 10